Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04288349Unknown
Randomised, double-blind trial in Hemorrhoids comparing Ropivacaine Group with Placebo Group (2 arms). Primary endpoint: The rate of opioid analgesics usage. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04288349.